Financial Gravity Asset Management’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10
Closed -$32 1211
2023
Q4
$32 Buy
+10
New +$24 ﹤0.01% 1189
2021
Q3
$13K Buy
291
+71
+32% +$983 0.01% 860
2021
Q2
$15K Buy
+220
New +$3.7K 0.01% 854
2020
Q4
$10K Buy
+387
New +$8.68K 0.01% 175
2019
Q4
$17K Sell
1,967
-1,196
-38% -$16K 0.01% 1063
2019
Q3
$33K Sell
3,163
-954
-23% -$12.8K 0.03% 359
2019
Q2
$64K Sell
4,117
-1,057
-20% -$18.9K 0.05% 280
2019
Q1
$96K Buy
+5,174
New +$91.7K 0.08% 207
2018
Q3
$99K Buy
3,968
+374
+10% +$10.7K 0.1% 215
2018
Q2
$101K Buy
3,594
+900
+33% +$26.8K 0.09% 215
2018
Q1
$78K Buy
+2,694
New +$85.1K 0.08% 221

Other funds holding CLLS

Financial Gravity Asset Management's CLLS Position: Q1 2024 in Review

Financial Gravity Asset Management sold out of Cellectis (CLLS) in Q1 2024, closing a stake of 10 shares — an estimated $32 sold.

Financial Gravity Asset Management first reported a position in CLLS in Q1 2018 and held it in 11 quarters. The position peaked at $101K in Q2 2018. 30 funds tracked by Wall St. Rank hold CLLS as of Q1 2024.

  • Financial Gravity Asset Management reported no remaining Cellectis position as of Q1 2024 after selling out during the quarter.
  • Financial Gravity Asset Management sold 10 Cellectis shares in Q1 2024, an estimated $32.
  • Financial Gravity Asset Management first reported a position in Cellectis in Q1 2018 and held it in 11 quarters.
  • Financial Gravity Asset Management's Cellectis position peaked at $101K in Q2 2018.
  • 30 funds tracked by Wall St. Rank held Cellectis as of Q1 2024.

Based on Financial Gravity Asset Management's 13F filing for Q1 2024, filed 13 May 2024.